Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production News

Electric car firm Tesla has announced it will be supplying mobile molecular printer capacity to German firm CureVac, and possibly others, to help...
Gilead features prominently in the news this week, as the US bought most of the world’s stock of the company’s drug remdesivir, which is one of the...
Covaxin, developed by Bharat Biotech, will begin testing for the treatment of the novel coronavirus in humans from July.
The FDA has awarded marketing authorisation in the US to Roche’s Phesgo, a combination of subcutaneously injected Herceptin (trastuzumab) with...
A new strain of flu has emerged in pigs in China, with scientists warning it has pandemic potential.
Featuring focuses on the importance of pharmaceutical sustainability and the economics of the revolutionary but deeply expensive CAR T cancer therapy...
Gilead has announced that it will charge $2,340 for a 5 day treatment course of remdesivir, a drug that has been proven to reduce the symptoms of...
The news this week centres on the pandemic in Europe, with the Independent SAGE group are warning that it is not safe to relax social distancing...
AstraZeneca has continued to build its manufacturing capacity to deliver its COVID-19 vaccine candidate, developed in partnership with the University...
Boehringer has revealed that it intends to withdraw its investment from Hikma Pharmaceuticals, with the company poised to sell 28 million shares to...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches